0

Purchase Short-Term Access

Intensive insulin therapy and starch (HES 200/0.5) had some risk and no clear benefit in severe sepsis
Deborah Cook, MD; Lauralyn McIntyre, MD


Annals of Internal Medicine 2008;148:JC4-4. doi:10.7326/0003-4819-148-12-200806170-02004

Purchase Online access to this article for 24 hours
Buy Now
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)